Cohere Health, a leader in clinical intelligence solutions for health plans and risk-bearing providers, announced it has raised $90 million in Series C funding. The funding round was led by Temasek, with continued support from Deerfield Management, Define Ventures, Flare Capital Partners, Longitude Capital, and Polaris Partners. This new investment brings Cohere’s total funding to $200 million.
Value proposition: With AI’s role in healthcare continues to draw scrutiny, Cohere’s clinician-led model and responsible AI-first approach ensure that clinical expertise remains at the core of every solution the company develops. And this strategy underpins the company’s commitment to innovation, accuracy, and accountability, offering a responsible and transparent model for healthcare automation.
Cohere’s platform provides measurable administrative and clinical efficiencies to streamline the authorization of pending services, reducing provider friction, accelerating time to care, and ultimately helping improve outcomes for health plan members. And the platform’s precision clinical insights mean up to 90% of requests can be auto-approved, helping providers spend less time on paperwork and more time with patients, and allowing for deeper collaboration between physicians and health plans on critical cases.
Momentum: In the past year, Cohere Health expanded its client base, strengthened its executive leadership team, and deepened platform adoption across the healthcare sector. And the company currently processes over 12 million prior authorization requests annually for more than 600,000 providers nationwide. Additionally, Gartner, LinkedIn, and KLAS have recognized Cohere’s contributions to advancing clinical intelligence, healthcare automation, and collaboration, reflecting its growing influence and sustained innovation in the field.
What the funding will be used for: The new funding round will advance Cohere’s next phase of growth, scaling the Cohere Unify platform, expanding into new clinical use cases, and deepening investment in its AI-powered product portfolio. And Cohere Unify enables critical collaboration points between health plans and providers, and modernizes utilization management (UM) by personalizing provider workflows and optimizing engagement through real-time performance data. Together, these capabilities lay the foundation for Cohere’s broader vision of transforming clinical decision-making.
KEY QUOTES:
“Our mission has always been simple: to help people receive the right care at the right time, in the right place, and with the right value. This funding is a catalyst to drive Cohere’s growth, expanding our industry-leading UM expertise into new use cases, scaling our operations, and allowing us to continue to transform how plans and providers collaborate to deliver care in ways that truly differentiate us.”
Siva Namasivayam, CEO and co-founder of Cohere Health
“Since the founding of the company, we have believed Cohere’s approach to AI is distinctive because it brings real clinical intelligence to the table. As the pioneer of the clinical intelligence category, they are not just digitizing an outdated system — they have reimagined prior authorization from the ground up to fundamentally change how clinical decisions are made by facilitating how plans and providers collaborate and incorporate best clinical evidence and guidelines. They have achieved an impressive 93% provider satisfaction rating and have dominated this category. The platform is well-positioned to serve other areas of the healthcare ecosystem. It has been gratifying to watch the company scale, and we are excited to continue our support for Cohere’s next chapter.”
Michael Greeley, Co-Founder & General Partner at Flare Capital Partners
